NIBEC CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17,190 KRW | -0.64% |
|
+1.48% | -20.60% |
| Sales 2022 | 21.67B 15.75M | Sales 2023 | 15.7B 11.42M | Capitalization | 219B 160M |
|---|---|---|---|---|---|
| Net income 2022 | -3.77B -2.74M | Net income 2023 | -6.28B -4.57M | EV / Sales 2022 | 8.06 x |
| Net cash position 2022 | 14.11B 10.26M | Net cash position 2023 | 5.06B 3.68M | EV / Sales 2023 | 13.7 x |
| P/E ratio 2022 |
-50
x | P/E ratio 2023 |
-
| Employees | 35 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.64% | ||
| 1 week | +1.48% | ||
| Current month | -7.58% | ||
| 1 month | -7.83% | ||
| 3 months | -2.05% | ||
| 6 months | +15.76% | ||
| Current year | -20.60% |
1 week
17 010.00
17 750.00
1 month
16 650.0021 050.00
Current year
16 290.0025 750.00
1 year
11 430.0025 900.00
3 years
11 430.0055 500.00
5 years
4 800.0055 500.00
10 years
3 950.0055 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 78 | - | |
Joo-Yeon Lee
BRD | Director/Board Member | 49 | - |
Yoon-Jeong Park
BRD | Director/Board Member | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 78 | - | |
Yoon-Jeong Park
BRD | Director/Board Member | 53 | - |
Joo-Yeon Lee
BRD | Director/Board Member | 49 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 17,190 | -0.64% | 37,873 |
| 24-04-25 | 17,300 | -1.93% | 30,744 |
| 24-04-24 | 17,640 | +0.74% | 43,545 |
| 24-04-23 | 17,510 | +0.34% | 29,041 |
| 24-04-22 | 17,450 | +3.01% | 44,967 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
NIBEC Co., Ltd. is a Korea-based company specialized in the manufacturing of dental medical products and supplies. The Company provides two main categories of products: dental health products and regeneration biomaterials. The dental health products consist of tooth whitening products under the brand name Blanc Tis; remedies for sensitive teeth under the brand name SensBlok, and dental conditioners under the brand name Clinplant. The regeneration biomaterials include bone graft materials under the brand name OCS-B, OCS-H and OCS-Collagen, as well as bone regenerative powders, bone morphogenetic materials, peptide bone powders and injectable gels. It also provides cosmetics under the brand name Skin Aropa. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -20.60% | 128M | |
| -28.51% | 925M | |
| -7.82% | 67.46M | |
| +6.64% | 60.58M | |
| +14.87% | 61.68M | |
| +0.60% | 51.45M |
- Stock Market
- Equities
- A138610 Stock
